An Open-label, Prospective, Randomized and Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2014
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen
- 10 Jun 2017 Biomarkers information updated
- 24 Jun 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 16 Aug 2012 Planned End Date changed from 1 Aug 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.